-CEO and directors buying in at 7.5 cents this Thursday
-6 million in cash and 4 million in rebates coming in (10 million in funding)
- drug developed and de risked over the past 4 years
- Target market 55 billion dollars
- Peers in same space 70-100 million market caps after pre clinical success
- 3 months away from first in human dose
- Backed by the Us defence department and de risked on current study from 2010
Worth the same as its finding funny. Keep dumping apparently there is no potential.
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-64
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $9.839M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.2¢ | $6.978K | 131.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2029207 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 49999 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| NYR (ASX) Chart |